U.S. judge approves $700 mln in Abbott Depakote fines, costs

WASHINGTON, Oct 2 (Reuters) - A federal judge on Tuesday sentenced Abbott Laboratories Inc to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said.

The pharmaceutical maker said in May it would plead guilty to a misdemeanor violation of misbranding.

Under terms announced then, Abbott agreed to pay $800 million in a civil settlement, a $700 million criminal penalty and $100 million to U.S. states to resolve consumer protection matters.

(Reporting by David Ingram; Editing by Gerald E. McCormick)

((David.Ingram@thomsonreuters.com)(+1 202 898 8396)(Reuters Messaging: David.Ingram.thomsonreuters.com@reuters.net))

Keywords: ABBOTT FINE/